The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity

Cancer Cell
Yizhou LiuJohn H Bushweller

Abstract

AML1/ETO is the chimeric protein resulting from the t(8;21) in acute myeloid leukemia. The Nervy homology 2 (NHR2) domain in ETO mediates oligomerization and AML1/ETO's interactions with ETO, MTGR1, and MTG16, and with the corepressor molecules mSin3A and HDAC1 and HDAC3. We solved the NHR2 domain structure and found it to be an alpha-helical tetramer. We show that oligomerization contributes to AML1/ETO's inhibition of granulocyte differentiation, is essential for its ability to enhance the clonogenic potential of primary mouse bone marrow cells, and affects AML1/ETO's activity on several endogenous genes. Oligomerization is also required for AML1/ETO's interactions with ETO, MTGR1, and MTG16, but not with other corepressor molecules.

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jul 1, 1990·Acta Crystallographica. Section A, Foundations of Crystallography·A T BrüngerJ W Erickson
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·Q WangN A Speck
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·J WangJ M Liu
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Nov 20, 1998·Molecular and Cellular Biology·B LutterbachS W Hiebert
Nov 25, 1998·Protein Science : a Publication of the Protein Society·E J SpekN R Kallenbach
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·D FasshauerR Jahn
Feb 2, 2000·Biophysical Journal·J García De La TorreB Carrasco
Dec 13, 2000·Molecular and Cellular Biology·J ZhangM A Lazar
Jan 21, 2001·The Journal of Biological Chemistry·D HildebrandA B Maurer
Jul 21, 2001·Molecular and Cellular Biology·F CalabiG Pavloska
Jan 12, 2002·Nature Structural Biology·Wolfram AntoninThomas R Schneider
Sep 28, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas R Schneider, George M Sheldrick
Oct 24, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas C Terwilliger
Feb 1, 2003·Gene·J Nathan DavisShari Meyers
Feb 11, 2003·Blood·Kamaleldin E ElagibAdam N Goldfarb
Apr 12, 2003·Journal of Cellular Biochemistry·Florian OttoMichael Stock
Oct 3, 2003·Cancer Cell·Mary Ellen MartinJay L Hess
May 8, 2004·Blood·Chi Wai So, Michael L Cleary
May 25, 2004·Oncogene·Luke F Peterson, Dong-Er Zhang
May 25, 2004·Oncogene·Bruce A Hug, Mitchell A Lazar
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Aug 31, 2004·Science·Jinsong ZhangRobert G Roeder
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ming YanDong-Er Zhang

❮ Previous
Next ❯

Citations

Oct 16, 2007·Oncogene·A N Goldfarb
Oct 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eun-Young AhnDong-Er Zhang
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Colin KwokChi Wai Eric So
Dec 12, 2012·Protein Engineering, Design & Selection : PEDS·Janina SpeckKristian M Müller
May 4, 2011·Molecular and Cellular Biology·Aubrey HuntScott W Hiebert
Jan 31, 2009·Blood·Liya RoudaiaNancy A Speck
May 1, 2010·Blood·Christian WichmannManuel Grez
Feb 3, 2007·BMC Genomics·Stefano RossettiNicoletta Sacchi
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Kentson Lam, Dong-Er Zhang
Jun 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jun ZhouHugues de Thé
Aug 19, 2014·Nature Reviews. Drug Discovery·Katrina J Falkenberg, Ricky W Johnstone
Aug 17, 2010·Journal of Molecular Biology·Takeshi CorporaJohn H Bushweller
May 1, 2007·The International Journal of Biochemistry & Cell Biology·Dominique VitouxHugues de The
Oct 9, 2009·Journal of Cellular Physiology·Kevin A LinkJames C Mulloy
Feb 6, 2016·PLoS Pathogens·Matthew R HarterJikui Song
Feb 10, 2017·Blood·Raman SoodPaul Liu
Feb 20, 2018·Archives of Virology·Sushant KumarK Suguna
Nov 13, 2007·Nature Genetics·Gang HuangDaniel G Tenen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.